Tim Morley

Tim is bringing 25 years of experience in the Pharmaceutical Industry with small molecules, peptides and natural products, directing discovery, safety evaluation and regulatory development. He has also gained expertise in Medical Device Safety & Biocompatibility as Site Director of Global Medtech Research Centre, establishing Centre of excellence for Biocompatibility, Safety & Efficacy. As a certified Toxicologist with additional expertise in DMPK, Clinical Chemistry, Pharmacology and Bioanalysis he will very much help Jellagen to scale up and enter in the world of medical device. His track record of directing therapeutic projects from Chemical Hit to IND managing US and EU Regulatory process and supporting orthopaedic, Sports Medicine & wound healing devices to successful 510K approval will be instrumental in advising Jellagen, as well as his experience of negotiating R&D collaboration contracts, managing industry/academic & biotech/Pharma collaborations.

Tim is currently Managing Director for Advotox Ltd, a Consultancy supporting Pharmaceutical, Biotechnology and Medical Device R&D. Tim is a Board-Certified Toxicologist and Fellow of the Royal College of Pathologists and gained his PhD in Mechanistic Toxicology at Aberdeen University. He also holds an MSc in Biopharmacy and BScs in Biochemistry and Pharmacology.

Prior to joining Jellagen Scientific Advisory Board, Tim was Senior Director of Preclinical Research and Site Director for the global Medtech company Smith & Nephew Research Centre at York for 4 years, responsible for developing and executing Preclinical Research strategies to support worldwide product approvals for advanced surgical devices and wound products – providing ISO-10993 Biocompatibility, Safety and Efficacy support for regulatory submission. He has also held several Directorial positions at Vernalis, as Senior Director of Biological Sciences for 7 years, where he was a Member of Senior Research Management team directing all CNS and Oncology research projects, Ardana Bioscience as Vice President of Preclinical Sciences for 4 years directing the Pre-Clinical development of all in-house projects and coordinating external academic research programmes, and CSO at Aquapharm Biodiscovery for 3 years were he directed the discovery of novel NCE Leads for Antibiotic, Antifungal, Anti-inflammatory, CNS and Oncology targets.